Boxer Capital Management, LLC Top Holdings and 13F Report (2026) About Boxer Capital Management, LLCInvestment ActivityBoxer Capital Management, LLC has $761.65 million in total holdings as of December 31, 2025.Boxer Capital Management, LLC owns shares of 54 different stocks, but just 20 companies or ETFs make up 80% of its holdings.Approximately 23.99% of the portfolio was purchased this quarter.About 3.39% of the portfolio was sold this quarter.This quarter, Boxer Capital Management, LLC has purchased 45 new stocks and bought additional shares in 13 stocks.Boxer Capital Management, LLC sold shares of 3 stocks and completely divested from 4 stocks this quarter.Largest Holdings Tango Therapeutics $227,530,501Kodiak Sciences $51,881,320Revolution Medicines $48,625,000Kymera Therapeutics $27,410,739Celcuity $25,681,500 Largest New Holdings this Quarter 92243G108 - Vaxcyte $18,885,750 Holding221015100 - Corvus Pharmaceuticals $16,093,000 Holding24477V105 - DEFINIUM THERAPEUTICS INC $11,311,650 Holding67577R102 - OPUS GENETICS INC $10,237,500 Holding218352102 - Corcept Therapeutics $10,077,500 Holding Largest Purchases this Quarter Vaxcyte 325,000 shares (about $18.89M)Corvus Pharmaceuticals 1,100,000 shares (about $16.09M)DEFINIUM THERAPEUTICS INC 598,500 shares (about $11.31M)Vir Biotechnology 1,241,000 shares (about $11.12M)OPUS GENETICS INC 2,250,000 shares (about $10.24M) Largest Sales this Quarter CYBIN INC 75,000 shares (about $360K)PepGen 101,000 shares (about $178.77K)INOVIO PHARMACEUTICALS INC 50,000 shares (about $87.00K) Sector Allocation Over TimeMap of 500 Largest Holdings ofBoxer Capital Management, LLC Selling Neutral Buying Latest 13F Holdings and Changes Since Previous Quarterly FilingIssuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSectorTNGXTango Therapeutics$227,530,5010.0%10,876,21929.9%MedicalKODKodiak Sciences$51,881,320$8,577,000 â–²19.8%1,361,0006.8%MedicalRVMDRevolution Medicines$48,625,000$9,725,000 â–²25.0%500,0006.4%MedicalKYMRKymera Therapeutics$27,410,7390.0%329,1003.6%MedicalCELCCelcuity$25,681,5000.0%225,0003.4%MedicalSURROZEN INC$22,322,843$10,200,394 â–²84.1%766,3182.9%COM NEWABIVAX SA$22,270,000$8,351,250 â–²60.0%200,0002.9%SPONSORED ADSTERNTerns Pharmaceuticals$19,770,0000.0%375,0002.6%MedicalPCVXVaxcyte$18,885,750$18,885,750 â–²New Holding325,0002.5%MedicalCAPRCapricor Therapeutics$17,936,000$8,056,000 â–²81.5%590,0002.4%MedicalPTGXProtagonist Therapeutics$17,918,0000.0%170,0002.4%MedicalVIRVir Biotechnology$16,719,360$11,119,360 â–²198.6%1,866,0002.2%MedicalCRVSCorvus Pharmaceuticals$16,093,000$16,093,000 â–²New Holding1,100,0002.1%MedicalPRAXIS PRECISION MEDICINES I$14,967,9810.0%46,4572.0%COM NEWPTCTPTC Therapeutics$13,626,0000.0%200,0001.8%MedicalPGENPrecigen$13,545,000$8,223,750 â–²154.5%3,500,0001.8%MedicalDEFINIUM THERAPEUTICS INC$11,311,650$11,311,650 â–²New Holding598,5001.5%COM SHSAMLXAmylyx Pharmaceuticals$11,120,0000.0%800,0001.5%MedicalQUREuniQure$10,823,700$6,082,200 â–²128.3%662,0001.4%MedicalOPUS GENETICS INC$10,237,500$10,237,500 â–²New Holding2,250,0001.3%COMCORTCorcept Therapeutics$10,077,500$10,077,500 â–²New Holding250,0001.3%MedicalURGNUrogen Pharma$8,990,0000.0%500,0001.2%MedicalREPLReplimune Group$8,988,750$3,251,250 â–²56.7%1,175,0001.2%MedicalCOGTCogent Biosciences$8,660,2500.0%225,0001.1%MedicalPALISADE BIO INC$8,399,7810.0%4,799,8751.1%COMCRESCENT BIOPHARMA INC.$8,334,212$8,334,212 â–²New Holding453,6861.1%COMSLNOSoleno Therapeutics$6,696,000$6,696,000 â–²New Holding200,0000.9%MedicalALLOAllogene Therapeutics$6,649,000$6,649,000 â–²New Holding2,725,0000.9%MedicalCYTKCytokinetics$6,591,0000.0%100,0000.9%MedicalCONTINEUM THERAPEUTICS INC$6,451,6400.0%494,0000.8%CL AAPOGEE THERAPEUTICS INC$5,891,9000.0%70,0000.8%COMRLMDRelmada Therapeutics$5,861,058$5,861,058 â–²New Holding842,1060.8%MedicalZURAZura Bio$5,355,000$5,057,500 â–²1,700.0%900,0000.7%MedicalMLTXMoonLake Immunotherapeutics$5,126,0000.0%275,0000.7%MedicalAVALO THERAPEUTICS INC$4,479,000$373,250 â–²9.1%300,0000.6%COM NEWINOVIO PHARMACEUTICALS INC$4,124,012$87,000 â–¼-2.1%2,370,1220.5%COM SHSGPCRStructure Therapeutics$3,615,0000.0%75,0000.5%MedicalSRPTSarepta Therapeutics$3,264,0000.0%150,0000.4%MedicalCYBIN INC$3,072,000$360,000 â–¼-10.5%640,0000.4%COM NEWOCULOcular Therapeutix$2,964,500$2,964,500 â–²New Holding350,0000.4%MedicalAN2 THERAPEUTICS INC$2,561,700$2,561,700 â–²New Holding749,0350.3%COMCLENE INC$2,354,149$1,369,446 â–²139.1%477,5150.3%COM NEWORICOric Pharmaceuticals$2,236,255$2,236,255 â–²New Holding176,5000.3%MedicalSLDBSolid Biosciences$2,160,0000.0%300,0000.3%MedicalIVVDInvivyd$1,950,0000.0%1,500,0000.3%MedicalLB PHARMACEUTICALS INC$1,726,2000.0%70,0000.2%COM SHSKARYOPHARM THERAPEUTICS INC$1,685,126$278,500 â–²19.8%302,5360.2%COM NEWNRIXNurix Therapeutics$1,550,0000.0%100,0000.2%MedicalUPSTREAM BIO INC$1,350,0000.0%150,0000.2%COMMISTMilestone Pharmaceuticals$793,3330.0%666,6660.1%MedicalPEPGPepGen$483,019$178,770 â–¼-27.0%272,8920.1%MedicalKALVKalVista Pharmaceuticals$410,6520.0%20,4000.1%MedicalRGNXREGENXBIO$125,700$125,700 â–²New Holding15,0000.0%MedicalSRZNWSurrozen$1,0670.0%66,6660.0%MedicalCIDARA THERAPEUTICS INC$0$11,707,170 â–¼-100.0%00.0%COM NEWMNMDMind Medicine (MindMed)$0$8,013,915 â–¼-100.0%00.0%MedicalCRESCENT BIOPHARMA INC.$0$5,380,716 â–¼-100.0%00.0%COMNUVATION BIO INC$0$88,000 â–¼-100.0%00.0%*W EXP 02/10/202Showing largest 100 holdings. View all holdings. More Institutional Buying and Selling Information SEC Filings and Trading Data SEC Filings 13F Filings Top 13F Buys Top 13F Sells Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.